Innoviva, Inc. (18)
Browse by Contract Category
Contracts
-
Third Amendment to Collaboration Agreement, dated July 13, 2022, by and among Innoviva, Inc., Glaxo Group Limited, and Theravance Respiratory Company, LLC
(Filed With SEC on July 13, 2022)
-
Equity Purchase Agreement, dated July 13, 2022, by and among Innoviva, Inc., Innoviva TRC Holdings LLC and Royalty Pharma Investments 2019 ICAV
(Filed With SEC on July 13, 2022)
-
Support Agreement, dated July 10, 2022, by and among Innoviva, Inc., Innoviva Acquisition Sub, Inc., Tang Capital Partners, LP and the Kevin C. Tang Foundation
(Filed With SEC on July 11, 2022)
-
Agreement and Plan of Merger, dated as of July 10, 2022, by and among Innoviva, Inc., Innoviva Acquisition Sub, Inc., and La Jolla Pharmaceutical Company
(Filed With SEC on July 11, 2022)
-
Amended and Restated Limited Partnership Agreement of ISP Fund LP, dated as of December 11, 2020, by and among ISP Fund LP, Sarissa Capital Fund GP LP, Innoviva Strategic Partners...
(Filed With SEC on December 14, 2020)
-
Transition Agreement between Innoviva, Inc. and Geoffrey L. Hulme, dated June 11, 2020
(Filed With SEC on June 12, 2020)
-
Lease Termination Agreement between Innoviva, Inc. and HCP Life Science Reit, Inc
(Filed With SEC on October 30, 2019)
-
Amendment No. 1 to the Investor Rights Agreement, dated May 23, 2022, by and among Innoviva, Inc. and Entasis Therapeutics Holdings Inc
(Filed With SEC on May 24, 2022)
-
Agreement and Plan of Merger, dated as of May 23, 2022, by and among Innoviva, Inc., Innoviva Merger Sub, Inc., and Entasis Therapeutics Holdings Inc
(Filed With SEC on May 24, 2022)
-
Offer Letter between Innoviva, Inc. and Pavel Raifeld, dated April 29, 2022
(Filed With SEC on May 2, 2022)
-
Form of Capped Call Confirmation
(Filed With SEC on March 8, 2022)
-
Indenture (including form of Note) with respect to Innovivas 2.125% Convertible Senior Notes due 2028, dated as of March 7, 2022, between Innoviva and The Bank of New York Mellon...
(Filed With SEC on March 8, 2022)
-
ISP FUND LP c/o Sarissa Capital Fund GP LP 660 Steamboat Road, 3rd Floor Greenwich, Connecticut 06830
(Filed With SEC on May 20, 2021)
-
SHARE REPURCHASE AGREEMENT
(Filed With SEC on May 20, 2021)
-
Indemnification Agreement, dated as of March 9, 2021, by and between Innoviva, Inc. and Deborah L. Birx, M.D
(Filed With SEC on April 28, 2021)
-
Strategic Advisory Agreement, dated as of December 11, 2020, by and between Sarissa Capital Management LP and Innoviva, Inc
(Filed With SEC on December 14, 2020)
-
Offer Letter between Innoviva, Inc. and Pavel Raifeld, dated May 20, 2020
(Filed With SEC on May 26, 2020)
-
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on February 19, 2020)